TGFβ inhibition prior to hypofractionated radiation enhances efficacy in preclinical models

Cancer immunology research

Volumn 2, Issue 10, 2014, Pages 1011-1022

  Young, Kristina H ^a   Newell, Pippa ^a   Cottam, Benjamin ^a   Friedman, David ^a   Savage, Talicia ^a   Baird, Jason R ^a   Akporiaye, Emmanuel ^a   Gough, Michael J ^a   Crittenden, Marka ^a  

^a PROVIDENCE PORTLAND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AZABICYCLO DERIVATIVE; SM16 COMPOUND; TRANSFORMING GROWTH FACTOR BETA;

ADAPTIVE IMMUNITY; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; C57BL MOUSE; CANCER TRANSPLANTATION; COLORECTAL NEOPLASMS; DRUG EFFECTS; DRUG SCREENING; FEMALE; IMMUNOLOGY; KAPLAN MEIER METHOD; MAMMARY NEOPLASMS, EXPERIMENTAL; PROCEDURES; RADIATION DOSE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL CULTURE;

ADAPTIVE IMMUNITY; ANIMALS; ANTINEOPLASTIC AGENTS; AZABICYCLO COMPOUNDS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; DRUG EVALUATION, PRECLINICAL; FEMALE; KAPLAN-MEIER ESTIMATE; LYMPHOCYTES, TUMOR-INFILTRATING; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOADJUVANT THERAPY; NEOPLASM TRANSPLANTATION; RADIATION TOLERANCE; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 84937511808     PISSN: None     EISSN: 23266074     Source Type: Journal    
DOI: 10.1158/2326-6066.CIR-13-0207     Document Type: Article

References (0)